Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

A simple chat or text could stop diabetes before it starts

NCT ID NCT07553325

First seen May 03, 2026 · Last updated Jun 19, 2026 · Updated 6 times

Summary

This pilot study tests whether a single, personalized conversation with a healthcare team member or a brief message through a patient portal can encourage adults with prediabetes to take action—like joining a diabetes prevention program or starting medication. Researchers will compare each approach to usual care in 120 patients at one clinic. The goal is to see if these simple strategies boost prevention steps.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PREDIABETES (INSULIN RESISTANCE, IMPAIRED GLUCOSE TOLERANCE) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Johns Hopkins Community Physicians Frederick

    Frederick, Maryland, 21702, United States

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Risk Informed Shared Decision-Making Strategy (RISE) and Low Touch Messaging Strategy (LTM)

What this could lead to

If successful, this could show that a brief, personalized risk discussion or a simple portal message can motivate people with prediabetes to join prevention programs or start medication.

What could go wrong

This is a small pilot study (120 people) at a single clinic, so results may not apply broadly. The interventions are very brief, and behavior change is hard to sustain.

Conditions

The condition(s) this trial relates to.

glucose intolerance Insulin Resistance prediabetes syndrome type 2 diabetes mellitus prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.